https://www.avient.com/sites/default/files/2022-02/Sustainability ESG Disclosures_Titanium Dioxide.pdf
PHYSICAL/CHEMICAL PROPERTIES DOCUMENT NUMBER_ SSS-002 CATEGORY DETAIL EC Number 236-675-5 CAS Number 13463-67-7 Name Subclass 1 Titanium Dioxide (TiO2) Structural Formula O======Ti====== O PROPERTY DETAIL Physical State Solid Form Crystalline Color White Odor Odorless Melting Point 1560–1843°C Boiling Point 3,000°C Bulk Density 3.9 g/mL at 25°C Water Solubility Immiscible DOCUMENT NUMBER_ SSS-002 HEALTH EFFECTS HUMAN HEALTH SAFETY ASSESSMENT Consumer Based on available data, TiO2 is not a hazardous substance.
Worker Workers should follow the recommended safety measures contained within the Safety Data Sheet (SDS) and on any product packaging.
Employees should be trained in the appropriate work processes and safety equipment to limit exposure to chemical substances.
https://www.avient.com/industries/healthcare/remote-monitoring-wearables/smartwatches-and-smart-rings
Wearable devices such as smartwatches and rings are revolutionizing how patients and healthcare professionals track and access medical data.
Mevopur™ Healthcare Colorants and Formulations
Mevopur™ Healthcare Bio-based Polymer Solutions
https://www.avient.com/industries/healthcare/medical-packaging/nutraceutical-packaging
Mevopur™ Healthcare Functional Additives
Mevopur™ Healthcare Colorants and Formulations
Mevopur™ Polymer Colorants and Additives
https://www.avient.com/sites/default/files/2024-05/Mevopur-Surgical Gown-Case study snapshot_0520.pdf
AVIENT SOLUTION SAFETY + COMPLIANCE Copyright © 2024 Avient Corporation.
All Rights Reserved. https://www.avient.com/products/polymer-colorants/healthcare-colorants/mevopur-healthcare-colorants-and-formulations Slide 1: Medical textile manufacturer
https://www.avient.com/news/‘future-proof’-pharma-packaging-avient-launches-new-regulatory-compliant-mevopur-amber-masterbatches
Homepage
//
News Center
//
‘Future-Proof’ Pharma Packaging: Avient Launches New Regulatory-Compliant MEVOPUR™ Amber Masterbatches
As a result, these MEVOPUR masterbatches will ‘future-proof’ pharma packaging and avoid the need for formulation changes in the years to come.”
The new MEVOPUR concentrates block wavelengths from 290 – 450 nm, while still providing good transparency.
https://www.avient.com/industries/healthcare/medical-packaging/medical-device-trays-and-kits
Mevopur™ Healthcare Functional Additives
Mevopur™ Healthcare Colorants and Formulations
Mevopur™ Polymer Colorants and Additives
https://www.avient.com/news/avient-launches-new-bio-based-polymer-solutions-medical-and-pharmaceutical-applications-during-pharmapack-europe-2022
These more sustainable additions to the Mevopur portfolio are being featured at Pharmapack Europe 2022, being held 18 and 19 May in the Paris Expo Porte de Versailles.
And, because they are produced under Mevopur protocols, these polymer solutions also can help the manufacturers reduce their risk of regulatory non-compliance.”
Manufactured using non-fossil feedstocks, the new Mevopur concentrates include polymers with bio-based content between 70 and 100%, as calculated to ASTM D6866 standard.
https://www.avient.com/resources/safety-data-sheets?page=6879
Avient has transitioned our Material Safety Data Sheets (MSDSs) to Safety Data Sheets (SDSs) for our manufactured products to meet the requirements of the Globally Harmonized System of Classification and Labeling of Chemicals (GHS), and CLP classification in Europe.
Technical Data Sheets
Safety Data Sheets
https://www.avient.com/resources/safety-data-sheets?page=7136
Avient has transitioned our Material Safety Data Sheets (MSDSs) to Safety Data Sheets (SDSs) for our manufactured products to meet the requirements of the Globally Harmonized System of Classification and Labeling of Chemicals (GHS), and CLP classification in Europe.
Technical Data Sheets
Safety Data Sheets
https://www.avient.com/sites/default/files/2023-01/Mevopur Healthcare Functional Additives Chemical Foaming Agents Application Bulletin.pdf
As part of our commitment, we publish Avient’s Mevopur™ product policy and use limitations to assist customers in their product selection.
Please be aware that there are certain applications Avient’s Mevopur products have not been designed for, nor are they promoted or intended for use in: including, but not limited to long-term or permanent implants, birth control devices, or plastic surgery.
For more detailed information on Mevopur uses and restrictions see www.avient.com/healthcare-use-limitations-mevopur-products or contact your Avient sales representative. 1.844.4AVIENT www.avient.com